Back

The effect of age on the efficacy and safety of dabigatran dual therapy in atrial fibrillation after PCI: a subgroup analysis from the RE-DUAL PCI trial

25 August 2018 (00:00 - 00:00)
Organised by:
Congress Presentation Part of: The ageing heart: a target for interventions and aggressive pharmacotherapy Cardiovascular Disease in the Elderly ESC Premium Access ESC Congress 2018

About the speaker

Photo
Ms Anne de Veer

St Antonius Hospital, Nieuwegein (Netherlands (The))

6 More presentations in this session

Presentation thumbnail
Impact of persistent pulmonary hypertension on the outcome of patients undergoing transcatheter aortic valve replacement
Associate Professor K. Toutouzas (Athens, GR)
Abstract Slides
Presentation thumbnail
Normal blood pressure by ACC / AHA 2017 is associated with higher mortality in older adults with hypertension over 1 year. Results of the SARCOS study.
Doctor J. Borges (Sao Paulo, BR)
Abstract Slides
Presentation thumbnail
Impact and predictive factors of bleeding complications in elderly patients admitted for an acute coronary syndrome: insights from the ANTARCTIC trial
Doctor B. Lattuca (Nimes, FR)
Abstract Slides
Presentation thumbnail
Effectiveness and safety of oral anticoagulants in patients aged 90 years or older with atrial fibrillation
Doctor M. Vedovati (Perugia, IT)
Abstract Slides
Presentation thumbnail
Elderly females with acute coronary syndrome present frailty and readmissions more frequently than males
Doctor L. Vicent Alaminos (Madrid, ES)
Abstract Slides

Access the full session

Session thumbnail
The ageing heart: a target for interventions and aggressive pharmacotherapy

The Event

Event poster

ESC Congress 2018

25 August - 29 August 2018

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources